BNC adds new consultants in China

BioNano Consulting (BNC) has signed up two new experts as part of an effort to build its presence in China.

The firm, which provides pharmaceutical and life science firms with consulting services, has agreed consultancy deals with Professors George Guo-Qiang Chen and Quan-Shui Zheng from Tsinghua University.

BNC’s CEO, Dr David Sarphie, said: “[the new consultants] bring further high level scientific expertise to our microbiological and nano technological service offering. Consequently, we look forward to providing access to their extensive research and development skills and running projects for the benefit of the Chinese life science market​.”

Professors Chen and Zheng join the firm as part of a wider global expansion program that, last year​, saw the London School of Pharmacy and Imperial College London JV launch its business in the US.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules | 09-Oct-2023 | White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...

Related suppliers

Follow us

Products

View more

Webinars